Telix Adds Lead-212 Isotope Production Capability
![]() |
MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated a breakthrough generator technology for the production of lead-212 (212Pb) and successfully completed first production.
The new generator technology,...
Read more: Telix Adds Lead-212 Isotope Production Capability





